Aug 21, 2020 10:31am EDT JanOne to Host Telebriefing to Discuss Drug Candidate JAN101 for Treatment of Peripheral Artery Disease (PAD) and Potential Applications for COVID-19 Vascular Complications
Aug 11, 2020 6:00pm EDT Correction -- JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials
Aug 11, 2020 9:37am EDT JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials
Aug 06, 2020 2:30pm EDT JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
Jul 30, 2020 9:30am EDT JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
Jul 21, 2020 9:25am EDT JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
Jul 08, 2020 9:30am EDT Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne's Scientific Advisory Board
Jun 30, 2020 9:30am EDT One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board